Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Nicotine Tob Res. 2024 Jul 22;26(8):1029-1037. doi: 10.1093/ntr/ntae032.
People with chronic hepatitis C virus (HCV; PWHC) use cigarettes at a much higher prevalence than other individuals, and smoking can exacerbate the harms specifically related to HCV (eg, hepatocellular carcinoma). Little is known about factors related to cigarette use among PWHC.
This study examined focus group data to explore beliefs and behaviors related to cigarette use among PWHC. Qualitative data from two focus groups of PWHC reporting current cigarette smoking (n = 15, 60% male) were collected using a semi-structured interview guide. Participants were asked about reasons for smoking, barriers to quitting smoking, and the relationship of HCV to smoking. Focus groups were transcribed verbatim and coded in NVivo 12. Four coders examined themes that arose in the focus groups. Common themes are described and supported with quotes.
Reasons for smoking included addiction to cigarettes, stress, substituting cigarettes for other drugs, and social norms, while reasons for quitting included health and being free from the use of all drugs. Barriers to quitting included concerns about coping with stress, weight gain, and having a lack of support for and education about quitting. Many participants believed there was a link between smoking and HCV and discussed smoking in relation to the stress of an HCV diagnosis.
Participants identified both HCV-related and non-HCV-related aspects of cigarette smoking and cessation-related behaviors that could be targeted in cessation treatment. More research is needed to identify the best treatment approaches that reduce the significant medical consequences of cigarette use among PWHC.
People with chronic hepatitis C virus (HCV; PWHC) smoke cigarettes at a high prevalence, yet little is known about their smoking behaviors. Moreover, there are no cessation treatments targeting PWHC. This is the first study to collect focus group data from PWHC who smoke in order to identify reasons for cigarette use (HCV-related and non-HCV-related), and motivators and barriers to quitting cigarettes. PWHC reports using cigarettes to cope with the stress of an HCV diagnosis and to celebrate HCV cure. These findings suggest there are specific times during the HCV care continuum where providers can aid with cessation efforts.
患有慢性丙型肝炎病毒(HCV;PWHV)的人吸烟的比例远高于其他人群,而吸烟会加剧与 HCV 相关的危害(例如肝细胞癌)。目前对于 PWHV 吸烟相关因素知之甚少。
本研究通过探讨 PWHV 吸烟相关信念和行为的焦点小组数据来检验假设。通过半结构化访谈指南收集了 2 个当前吸烟的 PWHV 焦点小组(n=15,60%为男性)的定性数据。参与者被问到吸烟的原因、戒烟的障碍,以及 HCV 与吸烟的关系。焦点小组的记录被逐字转录并在 NVivo 12 中进行编码。四位编码员检查了焦点小组中出现的主题。描述了共同主题,并提供了引用支持。
吸烟的原因包括对香烟的依赖、压力、用香烟代替其他毒品以及社会规范,而戒烟的原因包括健康和摆脱所有毒品的使用。戒烟的障碍包括对应对压力、体重增加以及缺乏戒烟支持和教育的担忧。许多参与者认为吸烟与 HCV 之间存在联系,并讨论了与 HCV 诊断相关的压力下吸烟的问题。
参与者确定了与 HCV 相关和非 HCV 相关的吸烟和戒烟相关行为方面,这些方面可以作为戒烟治疗的目标。需要进一步研究以确定减少 PWHV 吸烟带来的重大医疗后果的最佳治疗方法。
患有慢性丙型肝炎病毒(HCV;PWHV)的人吸烟率很高,但他们的吸烟行为却鲜为人知。此外,没有针对 PWHV 的戒烟治疗。这是第一项从吸烟的 PWHV 中收集焦点小组数据的研究,以确定吸烟的原因(与 HCV 相关和非 HCV 相关),以及戒烟的动机和障碍。PWHV 报告说,他们使用香烟来应对 HCV 诊断的压力,并庆祝 HCV 治愈。这些发现表明,在 HCV 护理连续体的特定时间,医生可以提供帮助。